Cancer Institute Put On Probation

The nation’s leading agency for certifying hospital quality has put the Dana-Farber Cancer Institute on probation after two recent cases involving overdoses of potent anticancer drugs.

The Joint Commission on the Accreditation of Healthcare Organizations downgraded DanaFarber’s accreditation from “full” to “conditional.”

The commission is giving the cancer institute six months to correct problems related to the chemotherapy overdoses, which led to the death of one patient and serious heart damage in another.